Nanosonics (ASX: NAN) – Files 2026 Preliminary Financial Report

Henry Fung

Henry is a co-founder of MF & Co. Asset Management with over 20 years in financial services as a trader and investor, including the past 10 years advising clients and building quantitative trading systems. Henry also maintains a high conviction list of 5 stocks that you can get for free and has a free 5-day course on how professionals use quantitative strategies to find an edge. The concepts in the course are applied in the Quantitative Leveraged ETF L/S Strategy.


August 25, 2026

Nanosonics (ASX: NAN)View stock profile →

I need the Nanosonics announcement text to write the commentary. The announcement section in your message came through empty. Could you paste the full announcement text, or point me to where it is in the Office? Once I have the details, I’ll write the 400-500 word analyst piece following your style guidelines.

View the full ASX announcement (PDF)

About Nanosonics Ltd (ASX: NAN)

Nanosonics Ltd is an Australian healthcare company that manufactures and distributes ultrasound probe disinfectors and related infection prevention technologies. The company’s flagship product, Trophon, is designed to reduce healthcare-acquired infections through high-level disinfection of ultrasound probes. Nanosonics operates across Australia, the United States, Canada, the United Kingdom, and Europe, serving the healthcare sector globally.

Our Exclusive Top 5 Stock Picks

Five high conviction stocks that didn't make the public list. Backed by institutional research with significant upside potential. Subscribe for free access.

Invalid email address
By subscribing, you consent to receive communications from us. You can unsubscribe at any time.

If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.

This is general advice only. MF & Co Asset Management has not considered your personal financial needs, objectives or current situation. This information is not an offer, solicitation, or a recommendation for any financial product unless expressly stated. You should seek professional investment advice before making any investment decision.

You May Also Like…

Subscribe

Want more Free Research?

Subscribe today for free and get an alert when we have new research and webinars.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.

MF & Co. Asset Management

MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.

We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.

Contact

Get In Touch

Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm

Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000

 

Products & Services

 

 

Share This